
Talking Biotech with Dr. Kevin Folta
by Colabra
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 31 chart positions in 31 markets.
By chart position
- 🇦🇺AU · Life Sciences#18300K to 1M
- 🇺🇸US · Life Sciences#6730K to 100K
- 🇨🇦CA · Life Sciences#7630K to 100K
- 🇩🇪DE · Life Sciences#1275K to 30K
- 🇬🇧GB · Life Sciences#1515K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
300K to 1.0M🎙 ~2x weekly·485 episodes·Last published 2mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
600K to 2.0M🇦🇺49%🇺🇸5%🇨🇦5%+28 more - Active Followers
Loyal subscribers who consistently listen
180K to 610K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 20 epsHosts
Recent guests
Recent episodes
Stop Political Interference in Federal Science Grants! With Dr. Colette Delawalla
Jul 3, 2026
56m 08s
The Future of Agriculture -- Dr. Scott Angle
Jun 29, 2026
59m 31s
Biotech Mold Detection and Health - Brian Karr
Jun 23, 2026
38m 43s
Dr. Neil Stewart-Radiation Sensing Potatoes
Jun 16, 2026
24m 28s
Milk Proteins without the Dairy - Adam Tarshis and Dr. Cory Tobin
Jun 9, 2026
47m 32s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/3/26 | scientific integrityfederal funding+3 | Dr. Colette Delawalla | Colabra | — | political interferencescientific integrity+3 | — | 56m 08s | ||
| 6/29/26 | future of agricultureAI innovations+4 | Dr. Scott Angle | University of Florida | — | agricultureAI+4 | — | 59m 31s | ||
| 6/23/26 | biotechmold detection+3 | Brian Karr | Talking BiotechColabra | — | biotech toolsmold detection+3 | — | 38m 43s | ||
| 6/16/26 | plant sensingsynthetic biology+3 | Dr. Neil Stewart | potato plantUniversity of Tennessee+1 | — | radiation sensingpotatoes+3 | — | 24m 28s | ||
| 6/9/26 | dairy alternativesplant-based proteins+3 | Adam TarshisDr. Cory Tobin | milk proteinscheese+1 | soybeans | milk proteinsdairy-free+4 | — | 47m 32s | ||
| 6/1/26 | burn carecell therapies+4 | Dr. Katie Bush | Aveda MedicalTalking Biotech | — | severe burnsburn treatment+5 | — | 28m 54s | ||
| 5/25/26 | cancer detectionDNA technologies+4 | Dr. Nate Montgomery | Neo Genomics Laboratories | — | molecular residual diseasecancer detection+3 | — | 37m 08s | ||
| 5/17/26 | Chronic Kidney Diseasehealth crisis+3 | Dr. Salvatore Viscomi | Carna HealthSiemens+1 | — | Chronic Kidney DiseaseCKD+5 | — | 37m 37s | ||
| 5/8/26 | AI in healthcarecancer research+3 | Dr. Emilia Javorsky | Future of Life InstituteTalking Biotech Podcast | — | AIhealthcare+4 | — | 39m 23s | ||
| 4/28/26 | genetic engineeringbiotechnology+3 | Dr. Steven Lindow | Talking BiotechColabra | — | ice minus bacteriafrost damage+3 | — | 25m 47s | ||
| 4/16/26 | therapeutic peptidesGLP-1 therapeutics+4 | Dr Karsten Eastman | GLP-1 therapeuticspeptide-based therapies+3 | — | Sathera Therapeuticspeptide-based therapies+1 | — | 33m 19s | ||
| 4/1/26 | genetic variationvegetative propagation+5 | Dr Danelle Seymour | Talking BiotechWashington Naval | — | genetic anomaliestree crops+2 | — | 28m 22s | ||
| 2/27/26 | conditionally active biologicsimmuno-oncology+3 | Dr Neela PatelDr Diane Hollenbaugh | Talking BiotechBonum Therapeutics+1 | — | Bonum Therapeuticsmarket landscape+1 | — | 46m 30s | ||
| 2/17/26 | cancer therapyimmunotherapy+2 | Dr Alexander Schneider | ElanogenTalking Biotech+1 | — | ElanogenP62 protein+3 | — | 44m 40s | ||
| 2/2/26 | biotechnologybeauty industry+6 | Nicholas Brideau | carmineDebut Biotech products+1 | — | biotechcosmetics+2 | — | 1h 12m 35s | ||
| 1/24/26 | molecular biologyDNA science+1 | — | — | — | 2025contributions+1 | — | 1h 10m 17s | ||
| 12/27/25 | glyphosaterisk assessment+1 | — | VeritassiumVeritasium | — | Veritasiumcontroversy+1 | — | 1h 11m 45s | ||
| 12/20/25 | glioblastomacancer research+1 | Dr Shiela SinghDr Thomas Graham | — | — | Cindy's Giftglioblastoma research+1 | — | 1h 04m 24s | ||
| 12/13/25 | human endogenous retrovirusesdisease+1 | Dr Avindra Nath | NIH | — | NIHproteins+1 | — | 50m 36s | ||
| 12/6/25 | plant breedinginterview+1 | Dr Maxine Thompson | — | — | — | — | 37m 40s |
Showing 20 of 20
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Similar Audience Demographics
Podcasts that attract a similar listener profile
Chart history for Talking Biotech with Dr. Kevin Folta
Peaked at #18 in Australia, currently #18 in Australia.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| Australia | — | #18 | #18 | — |
| Ireland | — | #19 | #19 | — |
| PT | — | #20 | #20 | — |
| India | — | #23 | #23 | — |
| HU | — | #24 | #24 | — |
| Norway | — | #31 | #31 | — |
| Mexico | — | #32 | #32 | — |
| AR | — | #45 | #45 | — |
| CH | — | #48 | #48 | — |
| AE | — | #49 | #49 | — |
| IL | — | #52 | #52 | — |
| Netherlands | — | #57 | #57 | — |
| SG | — | #59 | #59 | — |
| CZ | — | #64 | #64 | — |
| United States | — | #67 | #67 | — |
| TR | — | #71 | #71 | — |
| Canada | — | #76 | #76 | — |
| Finland | — | #85 | #85 | — |
| New Zealand | — | #88 | #88 | — |
| Brazil | — | #90 | #90 | — |
Chart Positions
33 placements across 31 markets.
Chart Positions
33 placements across 31 markets.